Research into the causes and potential treatments for Alzheimer’s disease has been as complicated as the disease itself. Patti Davis borrowed the phrase “The Long Goodbye” in describing the decline of her presidential father, and for good reason: This horrible affliction robs families of their dearest members with agonizing progression and frustration. And for researchers, it has for over a century hidden behind a shroud of mystery that is due partly to the complex nature […]
The first results from the GAP study of Intravenous Immunoglobulin (IGIV) for Alzheimer’s disease were just announced and are disappointing but not entirely discouraging. The primary results are clear — IGIV did not significantly slow decline of thinking abilities or preserve daily function in a large group of Alzheimer’s patients when compared to an inactive placebo. However, some positive responses were seen in certain subgroups of the participants who received IGIV. The GAP study was […]
